CRON News and Press, Cronos Group Inc. From 02/01/24

A lawsuit filed against the state of Mississippi by a medical cannabis dispensary owner has been dismissed. The lawsuit challenged Mississippi’s laws, which the plaintiff said placed restrictions on marijuana businesses by forbidding them from placing advertisements on a majority of medi...

2024-01-30 13:15:35 ET More on U.S. MSOs Alan Brochstein On Rescheduling Overexcitement, MSOs, Canada And The Burden Of 280E Trulieve's Bold Tax Strategy: A Game Changer In The U.S. Cannabis Sector Trulieve Is Cheap But Perhaps Risky HHS document shows recomm...

2024-01-30 07:30:06 ET 2024 Investing Guide: Best Canadian Cannabis Stocks to Consider The Canadian cannabis industry and top marijuana stocks witnessing a dynamic shift. This week, top Canadian cannabis stocks are in the spotlight. The market’s interest is heightened due to ...

2024-01-28 20:41:24 ET Summary Critics ask why buy Altria for its yield when the stock gives it all away to price depreciation. The answer is Altria has been hit by an adverse macro environment in 2023 which is about to reverse. This could see Altria turning around and again appre...

2024-01-25 13:00:00 ET Summary Alan Brochstein thinks investors are overly excited about the recent cannabis rescheduling announcement, which is not significant news. The burden of 280E and other financial challenges, debt and income tax payable. What's right and wrong with Ca...

TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that its brand, Spinach ® , closed 2023 as the number one ranked flower brand in...

2024-01-24 06:50:24 ET Will Federal Reform Lead To Bounce For Marijuana Stocks? With almost the first month of 2024 gone legal cannabis is put on the front lines once again. Over the next several months we will see more states try to not only pass legalization measures but improve u...

2024-01-21 11:02:27 ET Summary Trulieve's stock price is near a one-year high, outperforming other MSOs but not Tier 1 MSOs. Trulieve's growth is expected to be sluggish due to its dependence on the mature medical-only Florida cannabis market. Trulieve's valuation is relativel...

2024-01-19 13:09:07 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The fear of missing out generally results in losses as investors enter a stock at peak euphoria. The same story would have been ignored at cheap valuations. I, therefore, stay away from ideas t...

2024-01-18 17:15:21 ET Canadian Cannabis Stock Forecast: Q1 2024’s Must-Watch List As we delve into Q1 2024, the Canadian cannabis market and its top marijuana stocks continue to captivate investors’ attention. This sector, a trailblazer due to Canada’s early le...